Clinical efficacy of adalimumab versus infliximab and the factors associated with recurrence or aggravation during treatment of anal fistulas in Crohn's disease

BACKGROUND/AIMS: Infliximab has proven to be effective in the treatment of perianal fistulas in Crohn's disease (CD) but the efficacy of adalimumab is still unclear. The aim of this study is to assess the clinical efficacy of adalimumab and compare the results with those for infliximab. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Cheng-Chun, Takano, Shota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430009/
https://www.ncbi.nlm.nih.gov/pubmed/28522947
http://dx.doi.org/10.5217/ir.2017.15.2.182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430009/
https://www.ncbi.nlm.nih.gov/pubmed/28522947
http://dx.doi.org/10.5217/ir.2017.15.2.182

Ejemplares similares